TY - JOUR
T1 - Repurposing of Agrochemicals as ATTRv Amyloidosis Inhibitors
AU - Yokoyama, Takeshi
AU - Fujiwara, Satoru
AU - Nishikubo, Kai
AU - Mizuguchi, Mineyuki
AU - Nabeshima, Yuko
AU - Toyooka, Naoki
AU - Okada, Takuya
AU - Nakagawa, Yusuke
N1 - Publisher Copyright:
© 2025 American Chemical Society.
PY - 2025/1/23
Y1 - 2025/1/23
N2 - Transthyretin (TTR), a plasma protein, undergoes transformation into amyloid fibers, leading to ATTRv amyloidosis, a disease characterized by organ deposition of TTR amyloid fibrils and subsequent organ failure. Developing compounds that bind and kinetically stabilize TTR is a crucial strategy in the treatment of ATTRv amyloidosis. In this study, we narrowed 651 pesticide-related compounds down to 14 possible TTR binders through in silico screening; subsequent in vitro analysis revealed that 7 of them exhibited amyloid fibril formation inhibition activity. The herbicide components bromoxynil (6) and ioxynil (21) showed especially high ligand efficiency and efficiently inhibited amyloid fibril formation of amyloidogenic V30M-TTR. Additionally, aclonifen (9) exhibited moderate fibril formation inhibition activity, but showed selective binding to TTR comparable to that of tafamidis. While improvement is needed to the selective TTR-binding or fibril formation inhibition activity, the compounds identified herein are promising lead candidates for the development of ATTRv amyloidosis therapeutics.
AB - Transthyretin (TTR), a plasma protein, undergoes transformation into amyloid fibers, leading to ATTRv amyloidosis, a disease characterized by organ deposition of TTR amyloid fibrils and subsequent organ failure. Developing compounds that bind and kinetically stabilize TTR is a crucial strategy in the treatment of ATTRv amyloidosis. In this study, we narrowed 651 pesticide-related compounds down to 14 possible TTR binders through in silico screening; subsequent in vitro analysis revealed that 7 of them exhibited amyloid fibril formation inhibition activity. The herbicide components bromoxynil (6) and ioxynil (21) showed especially high ligand efficiency and efficiently inhibited amyloid fibril formation of amyloidogenic V30M-TTR. Additionally, aclonifen (9) exhibited moderate fibril formation inhibition activity, but showed selective binding to TTR comparable to that of tafamidis. While improvement is needed to the selective TTR-binding or fibril formation inhibition activity, the compounds identified herein are promising lead candidates for the development of ATTRv amyloidosis therapeutics.
UR - http://www.scopus.com/inward/record.url?scp=85214435874&partnerID=8YFLogxK
U2 - 10.1021/acs.jmedchem.4c02221
DO - 10.1021/acs.jmedchem.4c02221
M3 - 学術論文
C2 - 39761163
AN - SCOPUS:85214435874
SN - 0022-2623
VL - 68
SP - 1572
EP - 1586
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 2
ER -